Fosfomycin
Fosfomycin, sold under the brand name Monurol among others, is an antibiotic primarily used to treat lower urinary tract infections. It is not indicated for kidney infections. Occasionally it is used for prostate infections. It is generally taken by mouth.
Clinical data | |
---|---|
Trade names | Monuril, Monurol, Ivozfo, others |
Other names | Phosphomycin, phosphonomycin, fosfomycin tromethamine |
AHFS/Drugs.com | Monograph |
MedlinePlus | a697008 |
License data |
|
Routes of administration | Intravenous, By mouth |
ATC code | |
Legal status | |
Legal status | |
Pharmacokinetic data | |
Bioavailability | 30–37% (by mouth, fosfomycin tromethamine); varies with food intake |
Protein binding | Nil |
Metabolism | Nil |
Elimination half-life | 5.7 hours (mean) |
Excretion | Kidney, unchanged |
Identifiers | |
| |
CAS Number |
|
PubChem CID | |
DrugBank | |
ChemSpider | |
UNII | |
KEGG | |
ChEBI | |
ChEMBL | |
CompTox Dashboard (EPA) | |
ECHA InfoCard | 100.041.315 |
Chemical and physical data | |
Formula | C3H7O4P |
Molar mass | 138.059 g·mol−1 |
3D model (JSmol) | |
Melting point | 94 °C (201 °F) |
| |
| |
(verify) |
Common side effects include diarrhea, nausea, headache, and vaginal yeast infections. Severe side effects may include anaphylaxis and Clostridioides difficile-associated diarrhea. While use during pregnancy has not been found to be harmful, such use is not recommended. A single dose when breastfeeding appears safe. Fosfomycin works by interfering with the production of the bacterial cell wall.
Fosfomycin was discovered in 1969 and approved for medical use in the United States in 1996 . It is on the World Health Organization's List of Essential Medicines. The World Health Organization classifies fosfomycin as critically important for human medicine. It is available as a generic medication. It was originally produced by certain types of Streptomyces, although it is now made chemically.